Subscribe

Philippe Moreau, MD

University Hospital of Nantes

Articles by Philippe Moreau, MD

Philippe Moreau, MD

Promising Outlook in Multiple Myeloma with Cilta-Cel: Philippe Moreau, MD

ByPhilippe Moreau, MD

June 26th 2021

Philippe Moreau, MD, discussed the CARTITUDE-1 trial's promising results with ciltacabtagene autoleucel read out at the 2021 ASCO Annual Meeting.

Latest Updated Articles

Promising Outlook in Multiple Myeloma with Cilta-Cel: Philippe Moreau, MD
Published: June 26th 2021 | Updated:

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

Patients Treated With Spur Therapeutics’ Gaucher Disease Gene Therapy FLT201 Maintain Clinical Benefit for Up to 2 Years

CGTLive®’s Weekly Rewind – October 17, 2025

© 2025 MJH Life Sciences^®

All rights reserved.